Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Abp 959 - biosimilar to eculizumab	Eculizumab	[1] D03940 💬	[1] C5 💬	[9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	[1] 62 💬
2	Abp 959 - proposed biosimilar to eculizumab	Eculizumab	[1] D03940 💬	[1] C5 💬	[9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	[1] 62 💬
3	Eculizumab	Eculizumab	[1] D03940 💬	[1] C5 💬	[9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	[8] 11, 13, 14, 61, 62, 109, 222, 223 💬
4	Other: blood collection for measurement of eculizumab peak concentrations	Eculizumab	[1] D03940 💬	[1] C5 💬	[9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	[1] 62 💬
5	Other: eculizumab	Eculizumab	[1] D03940 💬	[1] C5 💬	[9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	[1] 109 💬
6	Sb12 (proposed eculizumab biosimilar)	Eculizumab	[1] D03940 💬	[1] C5 💬	[9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	[1] 62 💬
7	Soliris (eculizumab)	Eculizumab	[1] D03940 💬	[1] C5 💬	[9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	[1] 62 💬